Game-Changer on the Horizon: How Zumilokibart and a $10.9 Billion Acquisition Are Redefining the Future of Eczema Care
Executive Overview For millions of individuals coping with moderate-to-severe atopic dermatitis—commonly known as eczema—the daily reality extends far…
